From the Blog

New OSHA Pamphlet Suggests Hospitals More Dangerous Than You Think

February 5th, 2014

A new pamphlet published by the Occupational Safety and Health Administration (OSHA) called “How Safe Is Your Hospital for Workers?” includes some startling facts about the dangers that hospitals present not only to patients, but to their employees as well. For example, in terms of time lost due to illness and injury, hospital jobs (with…

Pennsylvania Supreme Court Stops Immunizing Big Pharma for Harmful Products

January 29th, 2014

The seemingly never-ending products liability case in Pennsylvania’s Supreme Court Lance v. Wyeth has finally drawn to a close after more than three years of arguments and appeals. This case involves Catherine Ruth Lance, whose family argues that Wyeth (a pharmaceutical company) was negligent in allowing an “unreasonably dangerous prescription drug on the market and…

Generic Drug Industry Still Largely Unchecked

January 22nd, 2014

In the past few months, this blog has addressed issues concerning the safety of generic drugs. In July we published an article about the Supreme Court protecting manufacturers of generics in cases in which victims were harmed due to inadequate warning labels. Fortunately, the FDA stepped in to try to impose stricter standards on such…

Bipartisan Budget Act Threatens Personal Injury Awards

January 15th, 2014

On December 26, 2013, President Obama and the House Budget Committee leadership reached a deal that set a new federal budget. The deal, according to Reuters, “reduces the risk of another government shutdown.” A less publicized section of the Bipartisan Budget Act, one that few news outlets have reported about, addresses personal injury claimants who…

Compounding Pharmacies Come Closer to Regulation

January 8th, 2014

About one year ago, a fungal meningitis outbreak in New England affected nearly eight hundred individuals in twenty states, claiming over sixty lives in the process. The source of these infections was the New England Compounding Center (NECC) in Massachusetts, which was an active distributor of the painkiller methylprednisone acetate, commonly used to treat chronic…

Health Canada Warns Doctors Cancer Drug Xeloda May Cause Stevens-Johnson Syndrome

December 11th, 2013

Over a year ago, this blog published an article about the dangers of Stevens-Johnson syndrome, a serious condition that causes a dark red rash to appear on the skin. Health Canada, Canada’s counterpart to the United States’ Food and Drug Administration (FDA), recently sent an open letter to health care professionals warning them that a drug,…

Study Claims Most Birth Asphyxia Cases Preventable

December 4th, 2013

Birth asphyxia, also known as birth hypoxia, or intrauterine hypoxia, occurs when a newborn is deprived of oxygen. This complication can lead to permanent brain damage and even death of the infant. In cases of brain damage, we typically see children diagnosed with cerebral palsy and neural tube defects. Babies who experience birth asphyxia are…

FDA Proposes New Generic Drug Warning Label Regulations

November 27th, 2013

It might surprise one to learn that 80 percent of pharmaceuticals currently prescribed in the United States are generic. But would it be surprising to know that brand-name drug manufacturers and those that make generic drugs were not always subject to the same rules? Earlier this year, this blog published a post detailing the Supreme…

Three New Tort Reform Proposals Reach the House

November 20th, 2013

The consumer activist and pro-civil justice blog ThePopTort.com informs us, somewhat in jest, that last week was the unofficial “House Tort Reform Week,” in which congressional leadership placed two so-called “tort reform” bills on the House floor and heard details in a subcommittee about a third. Despite overwhelming issues that plague this country following the…

Forbes’ Comprehensive, Fact-Based Critique of Tort Reform

November 13th, 2013

“Tort Reform” was back in the news last month thanks to an article in Forbes by Steve Cohen provocatively titled “Can Obamacare Improve Patient Safety? Tort Reform Hasn’t?” In it, Cohen argues what this blog has been asserting for years, that tort reform has not led to beneficial results for doctors, patients or the national…

 
 
© 2014 Feldman Shepherd Wohlgelernter Tanner Weinstock & Dodig LLP         Attorney Advertising         Disclaimer         Privacy Policy         Site Map
Personal Injury | Medical Malpractice | Auto Defects | Forklift Accidents | Tire Defects | Cerebral Palsy | Construction Accidents | Crashworthiness | Spinal Injury | Product Liability | Car Fires | Air Bag Defects